Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Am J Kidney Dis. 2015 Oct 31;67(5):792–810. doi: 10.1053/j.ajkd.2015.07.037

Table 4.

Kidney and extrarenal manifestations in ADPKD patients

PKD manifestation Frequency Comments
Kidney
Urinary concentration defect In up to 60% of children Earliest manifestation
Hypertension In 50-70% prior to GFR decline; Average age of onset, 30 Screen children with family history of ADPKD from age 5, then at 3-y intervals if negative
ESRD Occurs in 50% by age 60 Mean age of onset, 58 y
Proteinuria (>300 mg/d) Associated with GFR decline Prognostic marker
Abdominal/Flank Pain In 60% of adults Acute, chronic; multiple causes
Nephrolithiasis In 20-35% of patients Uric acid, Calcium oxalate composition
Cyst hemorrhage/gross hematuria In up to 60% of patients Most resolve within 2-7 d
Urinary tract infection In 30-50% of patients More common in women
Renal cell carcinoma In <1% of patients Risk not increased, may present with systemic symptoms
Extrarenal
Polycystic liver disease In >80% by age 30 Include liver imaging in initial visit
Intracranial aneurysm In 20-27% of those with positive family history of intracranial aneurysm; in 9% of those without such family history Screen if family history of intracranial aneurysm, personal history of intracranial hemorrhage, individuals with high-risk professions, pre-transplantation
Arachnoid cysts In 8-12% Possible increased risk of spontaneous subdural hematoma
Mitral valve prolapse In 25% Screen if symptoms
Pericardial effusion In up to 35% Screen if symptoms
Pancreatic cysts In 10% No screening needed
Diverticulosis In 20-25% of those with ESRD No screening needed
Bronchiectasis In up to 37% Mild, no screening needed
Congenital hepatic fibrosis rare No screening needed
Seminal vesicle cysts In up to 40% male patients No correlation to semen abnormalities
Male infertility associated with ADPKD Abnormal semen parameters reported

GFR, glomerular filtration rate; ADPKD, autosomal dominant polycystic kidney disease; ESRD, end-stage renal disease